Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
TV & Film
Sports
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/4c/f6/a6/4cf6a624-d428-20b0-10c1-dd3c550d58fc/mza_17773062139442729288.png/600x600bb.jpg
Freely Filtered, a NephJC Podcast
NephJC Team
85 episodes
1 day ago
NephJC covered the meta-analysis FINE HEARTS But Freely Filtered covered FINEARTS-HF the RCT of finerenone in heart failure with preserved ejection fraction
Show more...
Medicine
Health & Fitness,
Science
RSS
All content for Freely Filtered, a NephJC Podcast is the property of NephJC Team and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
NephJC covered the meta-analysis FINE HEARTS But Freely Filtered covered FINEARTS-HF the RCT of finerenone in heart failure with preserved ejection fraction
Show more...
Medicine
Health & Fitness,
Science
https://images.squarespace-cdn.com/content/v1/535bcb2fe4b05fe61b320c51/1745076741124-J9J46106RSBRG84VKCRA/Screenshot+2025-04-19+at+11.31.39%E2%80%AFAM.png?format=1500w
FF 79 REGENCY, Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
Freely Filtered, a NephJC Podcast
1 hour 42 minutes 51 seconds
7 months ago
FF 79 REGENCY, Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
Freely Filtered, a NephJC Podcast
NephJC covered the meta-analysis FINE HEARTS But Freely Filtered covered FINEARTS-HF the RCT of finerenone in heart failure with preserved ejection fraction